Actively Recruiting
Exposure Therapy for Late-life Anxiety
Led by ProPersona · Updated on 2025-05-29
170
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
Sponsors
P
ProPersona
Lead Sponsor
R
Radboud University Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective is to evaluate the (cost-)effectiveness of exposure therapy (ET) delivered by trained mental health nurses (MHNs) in terms of anxiety symptoms and quality of life for late life anxiety disorders in primary care compared to usual care (UC). UC is not restricted, and the general practitioner (GP) is encouraged to work according to the guidelines of the Dutch College of GPs. Participants in the ET group will receive 30-minute ET sessions delivered by a trained mental health nurse, during 8 sessions within the span of 12 weeks. Participants will fill in questionnaires before, during and after treatment, with a 1-year follow-up. The main study parameters are anxiety severity, quality of life and societal costs.
CONDITIONS
Official Title
Exposure Therapy for Late-life Anxiety
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A primary DSM-5 anxiety disorder diagnosed using the Mini International Neuropsychiatric Interview (MINI)
- Diagnosis of Generalized Anxiety Disorder, Agoraphobia, Panic Disorder, or Social Anxiety Disorder
- Sufficient proficiency in Dutch
You will not qualify if you...
- Presence of somatic or other psychiatric conditions interfering with diagnosis or treatment
- Moderate to severe suicidality as determined by the MINI
- Chronic and interfering substance or alcohol abuse
- Received psychotherapy including exposure therapy in the past year
- Score below 18 on the MoCa indicating moderate to severe cognitive impairment
- Terminal illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
RadboudUMC
Nederland, Nijmegen, Netherlands, 6525EZ
Actively Recruiting
Research Team
G
Gert-Jan Hendriks, Professor
CONTACT
N
Nessa Ikani, Asst. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here